ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Wednesday, 18 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Senores Pharmaceuticals Annual General Meeting

Senores Pharmaceuticals announced that shareholders passed two special resolutions via postal ballot, re-appointing Swapnil Shah as MD and Chetan Shah as whole-time director. Voting closed on 17 November 2026 with resolutions passing at over 99% in favour.

Source

NSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Senores Pharmaceuticals Ltd: key numbers

Share price
₹1,119.00
Market cap
₹5,153 Cr
Revenue (annual)
₹632.6 Cr
Net profit (annual)
₹115.4 Cr
P/E (TTM)
38.6×Sector 48.6×
Promoter holding
45.82%+0.00% QoQ
FII holding
6.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Senores Pharmaceuticals Ltd

All →
22:22 IST BSE
Regulatory Approval

Senores Pharmaceuticals Regulatory Approval

Senores Pharmaceuticals disclosed that its subsidiary Ratnatris Pharmaceuticals' Mehsana facility received PIC/S GMP certification from Ukraine's SMDC. The certificate, issued 16 November 2026, opens a wider pathway to regulatory approvals.

Other annual general meeting announcements

All →